This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Biomarin Pharmaceutical Inc (BMRN)

: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 397.04M 875.49M 568.78M 180.53M
Receivables 179.11M 201.15M 117.82M 109.07M
Inventories 271.68M 199.45M 162.60M 128.69M
Other Current Assets 10.92M 17.41M 41.71M 25.51M
Total Current Assets 1.09B 1.43B 1.14B 743.46M
Property, Plant & Equipment, Gross 982.81M 752.40M 504.36M 433.60M
Accumulated Depreciation & Depletion 278.60M 228.89M 185.04M 149.12M
Property, Plant & Equipment, Net 704.21M 523.52M 319.32M 284.47M
Intangibles 684.00M 156.58M 163.15M 162.98M
Other Non-Current Assets 834.30M 164.18M 424.69M 133.68M
Total Non-Current Assets 2.64B 1.06B 1.11B 858.18M
Liabilities & Shareholder Equity
Total Assets 3.73B 2.49B 2.25B 1.60B
Accounts Payable 232.24M 36.67M 48.78M 23.99M
Short Term Debt 0.00 0.00 0.00 23.36M
Other Current Liabilities 65.95M 5.48M 3.60M 2.07M
Total Current Liabilities 445.46M 235.74M 183.27M 170.43M
Long Term Debt 662.29M 657.98M 655.57M 324.86M
Deferred Income Taxes 143.53M 0.00 0.00 33.30M
Other Non-Current Liabilities 77.25M 68.84M 69.34M 57.29M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 883.06M 726.82M 724.90M 415.45M
Total Liabilities 1.33B 962.56M 908.18M 585.88M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 2.40B 1.53B 1.34B 1.02B
Common Par 162.00K 149.00K 144.00K 126.00K
Additional Paid In Capital 3.41B 2.36B 2.06B 1.56B
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -1.02B -849.77M -715.80M -539.45M
Treasury Stock -13.62M -9.70M -7.42M -6.60M
Other Equity Adjustments 21.03M 27.47M 5.02M -202.00K
Total Capitalization 3.06B 2.19B 2.00B 1.34B
Total Equity 2.40B 1.53B 1.34B 1.02B
Total Liabilities & Stock Equity 3.73B 2.49B 2.25B 1.60B
Total Common Shares Outstanding 161.53M 149.09M 143.46M 125.81M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 160.03M 146.35M 137.75M 120.27M
Diluted Weighted Shares Outstanding 160.03M 146.35M 137.75M 120.27M
Number of Employees 2158 1681 1341 1089
Number of Part-Time Employees 0 0 0 0
BMRN News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

BMRN Biomarin Pharmaceutical Inc

Chart of BMRN

Analysts Ratings for BMRN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 12 11 10 9
Moderate Buy 2 2 2 1
Hold 2 2 3 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET BMRN ANALYST REPORT

BMRN Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs